Diabetes
55:141-147,
2006
DOI: 10.2337/diabetes.55.01.06.db05-1077
© 2006 by the American Diabetes Association
Adiponectin Does Not Cross the Blood-Brain Barrier but Modifies Cytokine Expression of Brain Endothelial Cells
Joachim Spranger1,2,
Sulekha Verma3,4,
Isabel Göhring1,2,
Thomas Bobbert1,2,
Joseph Seifert5,
Amy L. Sindler6,
Andreas Pfeiffer1,2,
Stanley M. Hileman6,
Matthias Tschöp7, and
William A. Banks3,4
1 Department of Clinical Nutrition, German Institute of Human Nutrition, Potsdam, Germany
2 Department of Endocrinology, Diabetes and Nutrition, Charité-Universitymedicine Berlin, Berlin, Germany
3 Geriatric Research Educational Clincal Center, Veterans Affairs Medical Center, St. Louis, Missouri
4 Division of Geriatrics, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri
5 Department of Neurology, Charité-Universitymedicine Berlin, Berlin, Germany
6 Department of Physiology and Pharmacology, West Virginia University, Morgantown, West Virginia
7 Department of Psychiatry, Obesity Research Center, University of Cincinnati, Genome Research Institute, Cincinati, Ohio
Address correspondence and reprint requests to Joachim Spranger, MD, Dept. of Clinical Nutrition, German Institute of Human Nutrition Potsdam, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany. E-mail: spranger{at}mail.dife.de or joachim.spranger{at}charite.de
Abbreviations:
AMPK, cAMP kinase; BBB, blood-brain barrier; CNS, central nervous system; CSF, cerebrospinal fluid; IL, interleukin
Adiponectin has recently been reported to generate a negative energy balance by increasing energy expenditure. However, it is unclear whether such effects require the presence and direct action of the adiponectin protein in the central nervous system. In this study, neither radiolabeled nonglycosylated nor glycosylated globular adiponectin crossed the blood-brain barrier (BBB) in mice. In addition, adiponectin was not detectable in human cerebrospinal fluid using various established methods. Using murine cerebral microvessels, we demonstrated expression of adiponectin receptors, which are upregulated during fasting, in brain endothelium. Interestingly, treatment with adiponectin reduced secretion of the centrally active interleukin-6 from brain endothelial cells, a phenomenon that was paralleled by a similar trend of other proinflammatory cytokines. In summary, our data suggest that direct effects of endogenous adiponectin on central nervous system pathways are unlikely to exist. However, the identification of adiponectin receptors on brain endothelial cells and the finding of a modified secretion pattern of centrally active substances from BBB cells provides an alternate explanation as to how adiponectin may evoke effects on energy metabolism.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. D. Hoyda, M. Fry, R. S. Ahima, and A. V. Ferguson
Adiponectin selectively inhibits oxytocin neurons of the paraventricular nucleus of the hypothalamus
J. Physiol.,
December 15, 2007;
585(3):
805 - 816.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Neumeier, J. Weigert, R. Buettner, J. Wanninger, A. Schaffler, A. M. Muller, S. Killian, S. Sauerbruch, F. Schlachetzki, A. Steinbrecher, et al.
Detection of adiponectin in cerebrospinal fluid in humans
Am J Physiol Endocrinol Metab,
October 1, 2007;
293(4):
E965 - E969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. A. Banks, L. M. Willoughby, D. R. Thomas, and J. E. Morley
Insulin Resistance Syndrome in the Elderly: Assessment of functional, biochemical, metabolic, and inflammatory status
Diabetes Care,
September 1, 2007;
30(9):
2369 - 2373.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ebinuma, T. Miida, T. Yamauchi, Y. Hada, K. Hara, N. Kubota, and T. Kadowaki
Improved ELISA for Selective Measurement of Adiponectin Multimers and Identification of Adiponectin in Human Cerebrospinal Fluid
Clin. Chem.,
August 1, 2007;
53(8):
1541 - 1544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tanida, J. Shen, Y. Horii, M. Matsuda, S. Kihara, T. Funahashi, I. Shimomura, H. Sawai, Y. Fukuda, Y. Matsuzawa, et al.
Effects of Adiponectin on the Renal Sympathetic Nerve Activity and Blood Pressure in Rats
Experimental Biology and Medicine,
March 1, 2007;
232(3):
390 - 397.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bjursell, A. Ahnmark, M. Bohlooly-Y, L. William-Olsson, M. Rhedin, X.-R. Peng, K. Ploj, A.-K. Gerdin, G. Arnerup, A. Elmgren, et al.
Opposing Effects of Adiponectin Receptors 1 and 2 on Energy Metabolism
Diabetes,
March 1, 2007;
56(3):
583 - 593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kos, A. L. Harte, N. F. da Silva, A. Tonchev, G. Chaldakov, S. James, D. R. Snead, B. Hoggart, J. P. O'Hare, P. G. McTernan, et al.
Adiponectin and Resistin in Human Cerebrospinal Fluid and Expression of Adiponectin Receptors in the Human Hypothalamus
J. Clin. Endocrinol. Metab.,
March 1, 2007;
92(3):
1129 - 1136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fry, T. D. Hoyda, and A. V. Ferguson
Making Sense of It: Roles of the Sensory Circumventricular Organs in Feeding and Regulation of Energy Homeostasis
Experimental Biology and Medicine,
January 1, 2007;
232(1):
14 - 26.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Rodriguez-Pacheco, A. J. Martinez-Fuentes, S. Tovar, L. Pinilla, M. Tena-Sempere, C. Dieguez, J. P. Castano, and M. M. Malagon
Regulation of Pituitary Cell Function by Adiponectin
Endocrinology,
January 1, 2007;
148(1):
401 - 410.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Ahima, Y. Qi, N. S. Singhal, M. B. Jackson, and P. E. Scherer
Brain Adipocytokine Action and Metabolic Regulation
Diabetes,
December 1, 2006;
55(Supplement_2):
S145 - S154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fry, P. M. Smith, T. D. Hoyda, M. Duncan, R. S. Ahima, K. A. Sharkey, and A. V. Ferguson
Area postrema neurons are modulated by the adipocyte hormone adiponectin.
J. Neurosci.,
September 20, 2006;
26(38):
9695 - 9702.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Diabetes Association.
|
|
| |
|